Tort law

Global Fraud Detection and Prevention Market 2021-2027 - Booming e-Commerce Industry Aggravates the Risk of Fraud

Retrieved on: 
Wednesday, July 7, 2021

DUBLIN, July 7, 2021 /PRNewswire/ -- The "Fraud Detection and Prevention - Global Market Trajectory & Analytics" report has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • DUBLIN, July 7, 2021 /PRNewswire/ -- The "Fraud Detection and Prevention - Global Market Trajectory & Analytics" report has been added to ResearchAndMarkets.com's offering.
  • Amid the COVID-19 crisis, the global market for Fraud Detection and Prevention estimated at US$19.5 Billion in the year 2020, is projected to reach a revised size of US$51.3 Billion by 2027, growing at a CAGR of 14.8% over the period 2020-2027.
  • This segment currently accounts for a 36.5% share of the global Fraud Detection and Prevention market.
  • The country currently accounts for a 34.22% share in the global market.

Global Fraud Detection and Prevention Market Research Report 2021: Blockchain for Fraud Prevention - A New & Potent Weapon in the Making - ResearchAndMarkets.com

Retrieved on: 
Wednesday, July 7, 2021

The "Fraud Detection and Prevention - Global Market Trajectory & Analytics" report has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • The "Fraud Detection and Prevention - Global Market Trajectory & Analytics" report has been added to ResearchAndMarkets.com's offering.
  • Solutions, one of the segments analyzed in the report, is projected to grow at a 13.8% CAGR to reach US$30.6 Billion by the end of the analysis period.
  • This segment currently accounts for a 36.5% share of the global Fraud Detection and Prevention market.
  • The country currently accounts for a 34.22% share in the global market.

(PRVB) Deadline Alert: Investors Interested in Being a Lead Plaintiff in Securities Fraud Class Action Lawsuit Against Provention Bio – Contact Johnson Fistel

Retrieved on: 
Tuesday, July 6, 2021

The class action is on behalf of shareholders who purchased Provention between November 2, 2020 - April 8, 2021 both dates inclusive (the "Class Period").

Key Points: 
  • The class action is on behalf of shareholders who purchased Provention between November 2, 2020 - April 8, 2021 both dates inclusive (the "Class Period").
  • If you wish to serve as lead plaintiff in this class action, you must move the Court no later than July 20, 2021.
  • A lead plaintiff will act on behalf of all other class members in directing theProvention class action lawsuit.
  • An investor's ability to share any potential future recovery of theProvention class action lawsuit is not dependent upon serving as lead plaintiff.

CCXI Final Deadline: Bronstein, Gewirtz & Grossman, LLC Reminds ChemoCentryx, Inc. Investors of Class Action and Lead Plaintiff Deadline: July 6, 2021

Retrieved on: 
Tuesday, July 6, 2021

This class action seeks to recover damages against Defendants for alleged violations of the federal securities laws under the Securities Exchange Act of 1934.

Key Points: 
  • This class action seeks to recover damages against Defendants for alleged violations of the federal securities laws under the Securities Exchange Act of 1934.
  • To support its New Drug Application for avacopan, ChemoCentryx relied primarily upon its Phase III ADVOCATE study.
  • If you suffered a loss in ChemoCentryx you have until July 6, 2021 to request that the Court appoint you as lead plaintiff.
  • Your ability to share in any recovery doesn't require that you serve as a lead plaintiff.

FTC Issues Rule to Deter Rampant Made in USA Fraud

Retrieved on: 
Thursday, July 1, 2021

It will enable the Commission for the first time to seek civil penalties of up to $43,280 per violation of the rule.

Key Points: 
  • It will enable the Commission for the first time to seek civil penalties of up to $43,280 per violation of the rule.
  • In 1994, after the North American Free Trade Agreement took effect, Congress enacted legislation authorizing the FTC to seek penalties and other relief for Made in USA fraud, but only after the Commission issued a rule.
  • However, there had long been a bipartisan consensus at the FTC that Made in USA fraud should not be penalized.
  • By codifying this guidance into a formal rule, the Commission can increase deterrence of Made in USA fraud and seek restitution for victims.

FTC Issues Rule to Deter Rampant Made in USA Fraud

Retrieved on: 
Thursday, July 1, 2021

It will enable the Commission for the first time to seek civil penalties of up to $43,280 per violation of the rule.

Key Points: 
  • It will enable the Commission for the first time to seek civil penalties of up to $43,280 per violation of the rule.
  • In 1994, after the North American Free Trade Agreement took effect, Congress enacted legislation authorizing the FTC to seek penalties and other relief for Made in USA fraud, but only after the Commission issued a rule.
  • However, there had long been a bipartisan consensus at the FTC that Made in USA fraud should not be penalized.
  • By codifying this guidance into a formal rule, the Commission can increase deterrence of Made in USA fraud and seek restitution for victims.

"Never Events" Documentary Makes Streaming Debut This Week Showcasing Lives Destroyed by Unjust Medical Negligence Cap and Medical Harm, Says Consumer Watchdog

Retrieved on: 
Thursday, July 1, 2021

She works with families across the state of California to educate their community about the medical negligence cap and how they can protect themselves from medical negligence.

Key Points: 
  • She works with families across the state of California to educate their community about the medical negligence cap and how they can protect themselves from medical negligence.
  • The medical negligence cap, referred to as MICRA, was enacted in 1975 and has never been adjusted for inflation in 46 years.
  • Multiple Fairness Act patient advocates and women leaders in the movement to update the medical negligence cap were featured in the film.
  • An adjustment to the medical negligence cap would have helped Never Events star Annette Ramirez, a board member of Consumer Watchdog Campaign.

Neinstein Personal Injury Lawyers Launches New Website

Retrieved on: 
Wednesday, June 30, 2021

TORONTO, June 30, 2021 /CNW/ - Neinstein Personal Injury Lawyers is proud to announce the launch of our new website.

Key Points: 
  • TORONTO, June 30, 2021 /CNW/ - Neinstein Personal Injury Lawyers is proud to announce the launch of our new website.
  • Our team includes personal injury lawyers with experience in every variety of personal injury claim, including trauma lawyers , pedestrian lawyers , bike accident lawyers , motorcycle accident lawyers , car accident lawyers , birth injury lawyers , and more.
  • At Neinstein Personal Injury Lawyers (Neinstein LLP), we have advocated for injury victims for over 50 years.
  • About Neinstein Personal Injury Lawyers: Neinstein Personal Injury Lawyers is a Top 10 Personal Injury Boutique Law Firm based in Toronto, serving serious personal injury, accident injury, medical malpractice , and insurance dispute clients from across Ontario and Alberta.

CCIV Looming Deadline: Bronstein, Gewirtz & Grossman, LLC Reminds Churchill Capital Corp IV Investors With Losses Exceeding $500K of Class Action and Lead Plaintiff Deadline: July 6, 2021

Retrieved on: 
Tuesday, June 29, 2021

This class action seeks to recover damages against Defendants for alleged violations of the federal securities laws under the Securities Exchange Act of 1934.

Key Points: 
  • This class action seeks to recover damages against Defendants for alleged violations of the federal securities laws under the Securities Exchange Act of 1934.
  • When the true details entered the market, the lawsuit claims that investors suffered damages.
  • If you suffered a loss in Churchill you have until July 6, 2021 to request that the Court appoint you as lead plaintiff.
  • Your ability to share in any recovery doesn't require that you serve as a lead plaintiff.

(CCXI) Deadline Alert: Investors With Losses Over $100,000 Interested in Being a Lead Plaintiff in Securities Fraud Class Action Lawsuit Against ChemoCentryx Inc. – Contact Johnson Fistel

Retrieved on: 
Saturday, June 26, 2021

The class action is on behalf of shareholders who purchased ChemoCentryx betweenNovember 26, 2019, and May 6, 2021, both dates inclusive (the "Class Period").

Key Points: 
  • The class action is on behalf of shareholders who purchased ChemoCentryx betweenNovember 26, 2019, and May 6, 2021, both dates inclusive (the "Class Period").
  • If you wish to serve as lead plaintiff in this class action, you must move the Court no later than July 6, 2021.
  • A lead plaintiff will act on behalf of all other class members in directing theChemoCentryx class action lawsuit.
  • An investor's ability to share any potential future recovery of theChemoCentryx class action lawsuit is not dependent upon serving as lead plaintiff.